Collegium Pharmaceutical
COLL
24.72
-0.49
-1.94%
Collegium Pharmaceutical
US · COLL
#3535 by market cap
Listed 2015
24.72
-0.49
-1.94%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Company notice
Precision Optics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer COLL WAYNE MSEC · 2026/10/7
-
Rating change
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $48Market Newswire · 2026/8/19
-
Company notice
Precision Optics | 4: Statement of changes in beneficial ownership of securities-Officer COLL WAYNE MSEC · 2026/10/3
-
Rating change
H.C. Wainwright Reaffirms Their Buy Rating on Collegium Pharmaceutical (COLL)TipRanks · 2026/9/22
-
Truist Financial Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $49Market Newswire · 2026/11/6
-
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Cuts Target Price to $28Market Newswire · 2026/11/6
-
Company notice
Malayan Banking: Malayan Banking Berhad ("Maybank" or "the Company") . Proposed Establishment of a New Employee Share Option Scheme ("Proposed ESOS") . Proposed Amendments to the Articles of Association of Maybank ("Proposed Amendments") (to be collBursa Malaysia · 2004/1/26
-
H.C. Wainwright Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/11/6
-
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $48Market Newswire · 2026/10/15
-
Rating change
Truist Financial Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $49Market Newswire · 2026/9/9
-
Company notice
AWC: AWC FACILITY SOLUTIONS BERHAD ("AWC" or the "Company") . PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION OF AWC ("PROPOSED AMENDMENT"); AND . PROPOSED ESTABLISHMENT OF AN EMPLOYEE SHARE OPTION SCHEME ("PROPOSED ESOS") (COLLBursa Malaysia · 2004/4/27
-
Rating change
Leerink Partners Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $45Market Newswire · 2026/9/9
-
Company notice
Majuperak Holdings: UNITED CHEMICAL INDUSTRIES BERHAD (UCI or Company) . Proposed UCI Scheme . Proposed Harta Perak Acquisition . Proposed Majuperak Scheme . Proposed Transfer of Listing Status . Proposed Public Issue . Proposed Offer for Sale (collBursa Malaysia · 2003/4/10
-
Rating change
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Cuts Target Price to $43Market Newswire · 2026/8/7
-
Rating change
Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $56Market Newswire · 2026/5/13
-
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $41Market Newswire · 2026/11/14
-
Rating change
Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $46Market Newswire · 2026/8/7
-
Rating change
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $56Market Newswire · 2026/7/1
-
Rating change
Truist Financial Maintains Collegium Pharmaceutical(COLL.US) With Buy RatingMarket Newswire · 2026/5/15
-
Rating change
Analysts Are Bullish on These Healthcare Stocks: Collegium Pharmaceutical (COLL), Sionna Therapeutics, Inc. (SION)TipRanks · 2026/5/13
-
H.C. Wainwright Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/9/22
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Myriad Genetics (MYGN) and Mineralys Therapeutics, Inc. (MLYS)TipRanks · 2026/5/8
-
Rating change
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Maintains Target Price $44Market Newswire · 2026/4/23
-
Rating change
H.C. Wainwright Sticks to Its Buy Rating for Collegium Pharmaceutical (COLL)TipRanks · 2026/4/24
-
Rating change
A Quick Look at Today's Ratings for Collegium Pharmaceutical(COLL.US), With a Forecast Between $44 to $60Market Newswire · 2026/3/20
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Collegium Pharmaceutical discussion 0 comments